Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Intrinsic Therapeutics Completes $52M Financing To Fuel Commercial Efforts In The United States To Benefit Lumbar Discectomy Patients
Venture Capital

Intrinsic Therapeutics Completes $52M Financing To Fuel Commercial Efforts In The United States To Benefit Lumbar Discectomy Patients

by prnewswire.com posted 5months ago 150 views
BOSTON, April 11, 2019 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focusing on surgeries to treat leg and low back pain resulting from ruptured lumbar discs with large anular defects, today announced a $52m Series Growth equity financing. Questa Capital led the...

In this article